SCHEMBL9358145

SCHEMBL9358145

NC(=O)OC1CNC(C(=O)O)C1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.48
CYP1A2 P05177 2/20 0.48
ALOX15 P16050 2/20 0.48
CYP2C19 P33261 2/20 0.48
SLC1A3 P43003 1/20 0.48
SLC1A2 P43004 1/20 0.48
SLC1A1 P43005 1/20 0.48
ARG1 P05089 1/20 0.39
LMNA P02545 2/20 0.38
BLM P54132 2/20 0.38
TSHR P16473 1/20 0.38
RAB9A P51151 1/20 0.38
MEN1 O00255 1/20 0.38
THRB P10828 1/20 0.38
PMP22 Q01453 1/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1513773 1.00 CYP2D6 (0.48) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL11386525 1.00 CYP2D6 (0.48) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL2266841 1.00 CYP2D6 (0.48) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
Hydrochloric Acid SCHEMBL9835779 0.85 ATM (0.35) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL683739 0.81 CYP2D6 (0.48) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL3450044 0.81 CYP2D6 (0.48) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL3450045 0.81 CYP2D6 (0.48) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL5861606 0.81 CYP2D6 (0.48) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL23440323 0.80 CYP2D6 (0.52) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL444057 0.80 CYP2D6 (0.52) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0394989-B1 Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1994-12-21 EP claimed
US-5164372-A Treatment of respiratory disorders, inflammation, dermatitis FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-11-17 US claimed
EP-0394989-A2 Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-10-31 EP claimed
EP-0394989-B1 Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1994-12-21 EP disclosed
US-5164372-A Treatment of respiratory disorders, inflammation, dermatitis FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-11-17 US disclosed
EP-0394989-A2 Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-10-31 EP disclosed